News
MedImmune, AstraZeneca’s biologics arm, and NGM Biopharmaceuticals announce agreement to discover and develop therapies for diabetes and obesity
AstraZeneca announced that MedImmune, its global biologics research and development arm, and NGM Biopharmaceuticals, Inc. have entered into an exclusive agreement to discover, develop...
Drug Research
Takeda announces availability of type 2 diabetes drugs in US
Takeda Pharmaceutical Company has announced the availability of NESINA (alogliptin) and fixed-dose combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone) by...
Production & Manufacturing
Medicago wins European patent for influenza virus-like particles in plants
The European Patent Office (EPO) has granted Medicago a patent protecting exclusive rights to produce influenza virus-like particles (VLPs) in plants through July 2028....
Drug Research
Amedra re-launches Adrenaclick to treat anaphylaxis
Amedra Pharmaceuticals has re-launched a single-dose epinephrine auto-injector Adrenaclick for people with increased risk of anaphylaxis in both 0.15mg and 0.30mg strengths. ...
Packaging & Labelling
Canada unveils new labeling initiative to enhance drug safety
Canada has rolled out the plain language labeling initiative to improve the safe use of medicines by making drug labels and safety information easier...
Press Releases
Inspirational Sessions and Important Connections at Groundbreaking Scientific Healthcare Conference
The inaugural World Research and Innovation Congress took place at the Steigenberger Grandhotel in Brussels on 5 and 6 June. It was a truly...
Press Releases
Clovis Oncology Announces Upsizing and Pricing of Public Offering of Common Stock
Clovis Oncology announced today the pricing of an underwritten public offering of 3333334 shares of its common stock at $72.00 per share before underwriting...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read